Intrinsiqq
Cibus Inc. logo

Cibus Inc. (CBUS) Insider Trading

Last 12 months

No open-market buying or selling by insiders.

The last open-market buy by an executive or director was in Dec 2023.

Net open-market
$0
0 buys · 0 sales
Under a 10b5-1 plan
—
no sales
Insiders who bought / sold
0 / 0
executives and directors
Last open-market buy
Dec 2023
Dec 12, 2023

Get an email when CBUS's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Jun 13, 2025No plan
    Noel Sauer
    Sr VP, Research · sold 4 at $1.49
    $6
    <0.1% of stake
  • Feb 25, 202510b5-1 plan
    Gerhard Prante
    Director · sold 1,150 at $1.92
    $2k
    13% of stake
  • Feb 24, 202510b5-1 plan
    Gerhard Prante
    Director · sold 1,150 at $2.07
    $2k
    11% of stake
  • Feb 21, 202510b5-1 plan
    Gerhard Prante
    Director · sold 1,150 at $2.20
    $3k
    10% of stake
  • Feb 20, 202510b5-1 plan
    Gerhard Prante
    Director · sold 1,150 at $2.35
    $3k
    9.3% of stake
  • Feb 19, 202510b5-1 plan
    Gerhard Prante
    Director · sold 1,150 at $2.58
    $3k
    8.5% of stake
  • Feb 18, 202510b5-1 plan
    Gerhard Prante
    Director · sold 2,300 at avg $2.52
    $6k
    15% of stake
  • Feb 14, 202510b5-1 plan
    Gerhard Prante
    Director · sold 1,150 at $2.60
    $3k
    6.8% of stake
  • Feb 13, 202510b5-1 plan
    Gerhard Prante
    Director · sold 1,150 at $2.53
    $3k
    6.4% of stake
  • Feb 12, 202510b5-1 plan
    Gerhard Prante
    Director · sold 1,150 at $2.45
    $3k
    6.0% of stake
  • Feb 11, 202510b5-1 plan
    Gerhard Prante
    Director · sold 1,150 at $2.48
    $3k
    5.6% of stake
  • Feb 10, 202510b5-1 plan
    Gerhard Prante
    Director · sold 1,150 at $2.52
    $3k
    5.3% of stake
  • Feb 7, 202510b5-1 plan
    Gerhard Prante
    Director · sold 1,150 at $2.50
    $3k
    5.1% of stake
  • Feb 6, 202510b5-1 plan
    Gerhard Prante
    Director · sold 1,150 at $2.55
    $3k
    4.8% of stake
  • Feb 5, 202510b5-1 plan
    Gerhard Prante
    Director · sold 1,150 at $2.52
    $3k
    4.6% of stake
  • Feb 4, 202510b5-1 plan
    Gerhard Prante
    Director · sold 1,150 at $2.45
    $3k
    4.4% of stake
  • Feb 3, 202510b5-1 plan
    Gerhard Prante
    Director · sold 1,150 at $2.41
    $3k
    4.2% of stake
  • Jan 31, 202510b5-1 plan
    Gerhard Prante
    Director · sold 1,150 at $2.55
    $3k
    4.0% of stake
  • Jan 30, 202510b5-1 plan
    Gerhard Prante
    Director · sold 1,150 at $2.46
    $3k
    3.9% of stake
  • Jan 29, 202510b5-1 plan
    Gerhard Prante
    Director · sold 1,150 at $2.42
    $3k
    3.7% of stake
  • Jan 28, 202510b5-1 plan
    Gerhard Prante
    Director · sold 1,150 at $2.44
    $3k
    3.6% of stake
  • Jan 27, 202510b5-1 plan
    Gerhard Prante
    Director · sold 1,150 at $2.37
    $3k
    3.5% of stake
  • Jan 24, 202510b5-1 plan
    Gerhard Prante
    Director · sold 1,150 at $2.60
    $3k
    3.4% of stake
  • Jan 23, 202510b5-1 plan
    Gerhard Prante
    Director · sold 1,150 at $2.59
    $3k
    3.3% of stake
  • Jan 21, 2025 – Jan 22, 202510b5-1 plan
    Gerhard Prante
    Director · sold 2,300 at avg $2.41
    $6k
    6.1% of stake
  • Jan 21, 202510b5-1 plan
    Gerhard Prante
    Director · sold 1,150 at $2.50
    $3k
    3.0% of stake
  • Jan 17, 202510b5-1 plan
    Gerhard Prante
    Director · sold 1,150 at $2.50
    $3k
    2.9% of stake
  • Jan 15, 2025 – Jan 16, 202510b5-1 plan
    Gerhard Prante
    Director · sold 2,300 at avg $2.66
    $6k
    5.4% of stake
  • Jan 14, 202510b5-1 plan
    Gerhard Prante
    Director · sold 1,150 at $2.42
    $3k
    2.7% of stake
  • Jan 13, 202510b5-1 plan
    Gerhard Prante
    Director · sold 1,150 at $2.34
    $3k
    2.6% of stake
  • Jan 10, 202510b5-1 plan
    Gerhard Prante
    Director · sold 2,300 at avg $2.57
    $6k
    4.9% of stake
  • Jan 8, 202510b5-1 plan
    Gerhard Prante
    Director · sold 1,150 at $2.80
    $3k
    2.4% of stake
  • Jan 7, 202510b5-1 plan
    Gerhard Prante
    Director · sold 1,150 at $3.06
    $4k
    2.3% of stake
  • Jan 3, 2025 – Jan 6, 202510b5-1 plan
    Gerhard Prante
    Director · sold 2,300 at avg $3.02
    $7k
    4.5% of stake
  • Dec 19, 202410b5-1 plan
    Gerhard Prante
    Director · sold 1,150 at $3.45
    $4k
    2.2% of stake
  • Dec 18, 202410b5-1 plan
    Gerhard Prante
    Director · sold 1,150 at $3.75
    $4k
    2.1% of stake
  • Dec 16, 2024 – Dec 17, 202410b5-1 plan
    Gerhard Prante
    Director · sold 2,300 at avg $3.96
    $9k
    4.1% of stake
  • Dec 13, 202410b5-1 plan
    Gerhard Prante
    Director · sold 1,150 at $3.87
    $4k
    2.0% of stake
  • Dec 12, 202410b5-1 plan
    Gerhard Prante
    Director · sold 1,150 at $4.08
    $5k
    2.0% of stake
  • Dec 11, 202410b5-1 plan
    Gerhard Prante
    Director · sold 1,150 at $4.35
    $5k
    1.9% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch CBUS, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Agricultural Chemicals

Spot a number that looks wrong? Check it in CBUS's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing CBUS

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.